Trial intelligence / Profile preview

Combigan vs Cosopt on Ocular Blood Flow in Glaucoma

NCT00811850Phase 4Completed

Sponsor
Allergan
Start
Dec 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of brimonidine tartrate + timolol maleate in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Allergan. Started Dec 2008; status: completed.

02

Drugs

brimonidine tartrate + timolol maleate
03

Conditions

primary open-angle glaucoma (POAG)ocular hypertension

Beyond the preview

Go deeper on NCT00811850.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00811850.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call